Literature DB >> 20352586

Migraine-associated vertigo: diagnosis and treatment.

Yoon-Hee Cha1.   

Abstract

Migraine-associated vertigo has become a well-recognized disease entity diagnosed based on a clinical history of recurrent vertigo attacks unexplained by other central or peripheral otologic abnormalities, which occurs in the patient with a history of migraine headaches. There is no international agreement on what spectrum of symptoms should be covered under this diagnosis, or what terminology should be used. The headaches and vestibular symptoms of migraine-associated vertigo may not be temporally associated, which often obscures the association. Diagnostic tests usually show nonspecific abnormalities that are also seen in patients with migraine who do not experience vestibular symptoms. Management generally follows the recommended treatment of migraine headaches, and includes dietary and lifestyle modifications and medical treatment with beta blockers, calcium channel blockers, and tricyclic amines. Small case series show that acetazolamide and lamotrigine appear to be more effective for the vertigo attacks than headaches. Vestibular rehabilitation has also been shown to be helpful in several studies. In this review, the epidemiologic and clinical features of the disorder, as well as the current state of knowledge on pathophysiology, diagnostic testing, and treatment are described. Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352586      PMCID: PMC5682200          DOI: 10.1055/s-0030-1249225

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  87 in total

1.  Episodic vertigo related to migraine (90 cases): vestibular migraine?

Authors:  M Dieterich; T Brandt
Journal:  J Neurol       Date:  1999-10       Impact factor: 4.849

2.  Coexistence of acetylcholine and calcitonin gene-related peptide in the vestibular efferent neurons in the rat.

Authors:  K Ohno; N Takeda; M Yamano; T Matsunaga; M Tohyama
Journal:  Brain Res       Date:  1991-12-06       Impact factor: 3.252

3.  Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.

Authors:  C Lampl; A Buzath; D Klinger; K Neumann
Journal:  Cephalalgia       Date:  1999-01       Impact factor: 6.292

4.  Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers.

Authors:  J M Winterkorn; M J Kupersmith; J D Wirtschafter; S Forman
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

5.  Menière's disease. Etiologic considerations.

Authors:  W Parker
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-04

6.  Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

Authors:  T W Ho; L K Mannix; X Fan; C Assaid; C Furtek; C J Jones; C R Lines; A M Rapoport
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

7.  Migraine-associated dizziness.

Authors:  F M Cutrer; R W Baloh
Journal:  Headache       Date:  1992-06       Impact factor: 5.887

8.  The prevalence of migraine in Menière's disease.

Authors:  C H Rassekh; L A Harker
Journal:  Laryngoscope       Date:  1992-02       Impact factor: 3.325

9.  Clinical spectrum of episodic ataxia type 2.

Authors:  J Jen; G W Kim; R W Baloh
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

10.  Audiometric findings of patients with migraine-associated dizziness.

Authors:  Robert A Battista
Journal:  Otol Neurotol       Date:  2004-11       Impact factor: 2.311

View more
  11 in total

1.  Management of vestibular migraine.

Authors:  Alexandre R Bisdorff
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

Review 2.  Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.

Authors:  Michael Strupp; Matthew J Thurtell; Aasef G Shaikh; Thomas Brandt; David S Zee; R John Leigh
Journal:  J Neurol       Date:  2011-04-02       Impact factor: 4.849

3.  Perspectives in vestibular diagnostics and therapy.

Authors:  Arneborg Ernst
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

Review 4.  Nimodipine in otolaryngology: from past evidence to clinical perspectives.

Authors:  D Monzani; E Genovese; L A Pini; F Di Berardino; M Alicandri Ciufelli; G M Galeazzi; L Presutti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

Review 5.  Effects of Vestibular Rehabilitation in the Management of a Vestibular Migraine: A Review.

Authors:  Ahmad H Alghadir; Shahnawaz Anwer
Journal:  Front Neurol       Date:  2018-06-12       Impact factor: 4.003

Review 6.  The Prevalence of Dizziness and Vertigo in COVID-19 Patients: A Systematic Review.

Authors:  George Korres; Dimitrios K Kitsos; Diego Kaski; Anthi Tsogka; Sotirios Giannopoulos; Vasileios Giannopapas; Giorgos Sideris; Giorgos Tyrellis; Konstantine Voumvourakis
Journal:  Brain Sci       Date:  2022-07-20

Review 7.  Epilepsy and the cortical vestibular system: tales of dizziness and recent concepts.

Authors:  Russell Hewett; Fabrice Bartolomei
Journal:  Front Integr Neurosci       Date:  2013-11-11

8.  A recurrent headache circumscribed in a coronal line-shaped area around the head: a coronal linear headache.

Authors:  Lei Wang; Jie-Feng Pan; Yun-Yun Lu; Liang-Hui Hu; Ya-Nan Lu; Qing-Qing Pan; Yu Wang
Journal:  Springerplus       Date:  2016-03-10

9.  Comprehensive Clinical Profile of Mal De Debarquement Syndrome.

Authors:  Yoon-Hee Cha; Yong Yan Cui; Robert W Baloh
Journal:  Front Neurol       Date:  2018-05-07       Impact factor: 4.003

Review 10.  Frontal lobe epilepsy manifesting as vertigo: a case report and literature review.

Authors:  Yongning Jiang; Xiangqin Zhou
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.